Eukaryotic translation initiation factors 3B (EIF3B), serving as a scaffolding subunit, has been verified to be overexpressed in colon cancer, bladder and prostate cancer, glioblastoma, etc. and also made difference in the biological characteristics of cancer cells [7–9]. Here, EIF3B is linked to prostate carcinoma.